Digg It
#1 in Business Subscribe Email Print

You are here: Home > Business > Fundraising > Fundraising or Fund Development - What's the Difference?

Tags

  • drugs
  • these
  • device
  • biological product
  • meeting space

  • Links

  • Affordable Housing in Florida? Don't Miss Holiday in Pasco County
  • Key Aspects of Bad Credit Personal Loans
  • Abdominoplasty Primer: What is a Tummy Tuck?
  • Digg It - Fundraising or Fund Development - What's the Difference?

    The terms fundraising and fund development are bantered about almost interchangeably. But, there is a difference. Here’s my attempt at an explanation.

    Fundraising is probably the easiest of the two terms to define. It is activity that is conducted with
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    the intention of raising money for a nonprofit organization or charity. It usually involves asking people for donations, using a variety of communication methods, asking people to purchase a product or service that supports the charity, or having people
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    participate in an event of some sort. Some extend the definition of fundraising to include activities like sponsorship sales, which is essentially a form of advertising, gaming and gambling activities that benefit charity, and application for funds from
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    government programs.

    Fund development is a bit less straight-forward and a bit more of an abstract concept. The way I think of fund development is the process by which organizations use fundraising to build capacity and sustainability. Fund development
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    is a part of the strategic marketing of a nonprofit organization. It is the concerned not only with raising money, but doing so in a way that develops reliable sources of income that will sustain the organization through the realization of its long term
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    ission and vision. Fund development usually involves building relationships with people and other organizations that will support the charity. It requires a strategic plan that relates funding to the purpose and programs of the organization. A part of th
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    e strategic plan will be a fund development plan that coordinates various forms of fundraising, marketing, communications, and volunteer management.

    There are various ways of categorizing nonprofit organizations and charities. When it comes to determini
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    g which require fund development strategies, as opposed to fundraising, I tend to think in terms of three categories. There are organizations that do not concern themselves with development because the membership keeps changing, the goal for fundraising
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    s almost always to meet the immediate needs of the members, and the infrastructure costs are supplied by a larger, affiliated organization. Church youth groups, bands, cheerleading squads, and sports teams, and so on, fit into this category. Participants
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    in these groups are usually involved for a few years, so typically no long term relationships with people outside the group are established, their is no incentive for members to fundraise beyond their immediate needs and they are usually affiliated with
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    arger groups, like schools or churches, which supply needs like meeting space and leadership. These types of groups typically engage in fundraising activities that require minimal organization, leverage volunteer participation and require simple communic
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    ation strategies.

    A second type of organization is primarily member based. Funds are raised from among the members themselves for the purpose of sustaining the organization's needs, which are usually a building or meeting space of some sort and staff. T
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    e money required may be in the form of fees paid to belong to the organization, as in the case of a professional association, or in the form of donations, as in the case of a church. These organizations have a built-in fund development strategy. The su
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    porters of the organization are the recipients of the organization's programs and services. So the strategy for sustaining the organization and building its capacity usually revolves around the members themselves organizing in a way that provides trust o
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    the leadership to spend funds wisely, communication about how funds are being used, involvement of the membership in budgeting and other decision making processes, and a strategy to build and rejuvenate the membership.

    The third type of organization po
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    entially describes the rest of the nonprofit and charitable world. This is the organization that serves the entire community or society in some way. It has a long term vision and strategic plan and requires funding to maintain its service to the communi
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    ty year after year. Sometimes organizations like this have a base of government support, but often must raise funds from a variety of sources to maintain their budgets. This type of organization must have a fund development strategy in place to ensure it
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    long term viability and build its capacity over time. The methods of fundraising it uses may be similar to the other organizations described above, the difference being that underlying its choice of fundraising methods will be the desire to build sustai
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    able relationships with all funding sources.

    A key decision an organization must make is what type of fundraising or fund development strategy it should use based on the type of organization it is and if it has long-term needs. Many organizations start
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    ith meeting their needs through short-term fundraising strategies and at some point must make the transition to fund development strategies. Otherwise, they will flounder, moving from one fundraiser to another without developing sustainable relationships


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.diggit.org.ua/article/19685/diggit-Fundraising-or-Fund-Development--Whats-the-Difference.html">Fundraising or Fund Development - What's the Difference?</a>

    BB link (for phorums):
    [url=http://www.diggit.org.ua/article/19685/diggit-Fundraising-or-Fund-Development--Whats-the-Difference.html]Fundraising or Fund Development - What's the Difference?[/url]

    Related Articles:

    Brand Aid: How to Sell Yourself

    Career Networking - 5 Top Job Finding Tactics

    The 12 Most Common Mistakes New Entrepreneurs Make & How to Avoid Them

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com